21 related articles for article (PubMed ID: 3461747)
1. Prophylactic Antiemetics for Haematological Malignancies: Prospective Nationwide Survey Subset Analysis in Japan.
Yoshida I; Tamura K; Miyamoto T; Shimokawa M; Takamatsu Y; Nanya Y; Matsumura I; Gotoh M; Igarashi T; Takahashi T; Aiba K; Kumagai K; Ishizawa K; Kurita N; Usui N; Hatake K
In Vivo; 2019; 33(4):1355-1362. PubMed ID: 31280230
[TBL] [Abstract][Full Text] [Related]
2. [Phase II study of epirubicin on breast cancer: a cooperative group study].
Tominaga T; Kitamura M; Nomura Y; Abe O; Enomoto K; Ikeda T; Izuo M; Iino Y; Taguchi T; Tamura K
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2187-92. PubMed ID: 3459397
[TBL] [Abstract][Full Text] [Related]
3. [Phase II study of epirubicin in inoperable or recurrent gastric cancer].
Sakata Y; Yoshida Y
Gan To Kagaku Ryoho; 1986 May; 13(5):1887-92. PubMed ID: 3458431
[TBL] [Abstract][Full Text] [Related]
4. [Phase II study of epirubicin on gastric cancer--a cooperative study of the Tokai Cancer Chemotherapy Group].
Kimura K; Suga S; Kano H; Sakakibara K; Hayashi T; Nakai T; Nagano I; Yokoyama Y; Morise K; Hayakawa M
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2440-5. PubMed ID: 3460530
[TBL] [Abstract][Full Text] [Related]
5. [A phase I study of 4'-epi-adriamycin, a new anthracycline anticancer agent].
Kimura K; Wakui A; Saito T; Tominaga T; Niitani H; Fujimoto T; Masaoka T; Toki H; Tamura K
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2414-9. PubMed ID: 6594078
[TBL] [Abstract][Full Text] [Related]
6. Phase I-II trial of high-dose epirubicin in patients with lymphoma.
Case DC; Gams R; Ervin TJ; Boyd MA; Oldham FB
Cancer Res; 1987 Dec; 47(23):6393-6. PubMed ID: 3479245
[TBL] [Abstract][Full Text] [Related]
7. [Epirubicin (4'-epi-adriamycin].
Tsukagoshi S
Gan To Kagaku Ryoho; 1990 Jan; 17(1):151-9. PubMed ID: 2404456
[TBL] [Abstract][Full Text] [Related]
8. Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.
Cersosimo RJ; Hong WK
J Clin Oncol; 1986 Mar; 4(3):425-39. PubMed ID: 3005521
[TBL] [Abstract][Full Text] [Related]
9. [A phase II study of epirubicin in malignant lymphoma].
Masaoka T; Shibata H; Sampi K; Hirota Y; Yoshida Y; Chiba Y; Shirakawa S; Kobayashi T; Toki H; Tamura K
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2606-11. PubMed ID: 3461747
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study of adriamycin, epirubicin and mitoxantrone in cancer of the breast. Review of the literature].
Delozier T; Vernhes JC
Bull Cancer; 1991 Nov; 78(11):1013-25. PubMed ID: 1369547
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]